Healthcare tech innovator Augnito has taken on board Sahil Deswal as the Chief Marketing Officer for the brand. At Augnito, Deswal will be responsible for leading marketing strategy, including digital media strategy and advertising, as well as brand growth, with a strong focus on global brand building.
Deswal comes with over a decade of experience and has played an instrumental role in driving marketing and growth efforts for brands across e-commerce, media and entertainment, content, digital agencies and online services.
Prior to joining Augnito, Deswal was VP, Marketing, Growth and Monetisation at Trell. In his previous stints, he has worked with Unilodgers as VP, Global Growth and Marketing and as Head, Growth and Marketing at Times Internet for News and Gaming Business.
Rustom Lawyer, Founder and CEO, Augnito, said, âWe are thrilled to have Sahil on board and have him join our growth journey. At Augnito, it is our constant endeavour to ensure we make a difference with our voice technology and weâre certain that with Sahilâs appointment, we will be able to amplify our message and accelerate our journey of disrupting the healthcare technology space in India and the world.â
Deswal said, âAugnito has done a phenomenal job in transforming and aiding healthcare professionals in India especially during times like these when healthcare is the topmost priority.Â I am thrilled to join an organisation which I am confident will transform the face of healthcare globally and take digitisation to newer heights. I look forward to leveraging my expertise for the brand, weâre just getting started and I am excited for the journey ahead.â
Developed in India after years of extensive research and co-designed by doctors and leading AI scientists, Augnito is a cloud-based speech-to-text software that guarantees error-free documentation, by converting human voice to written text in real-time. Augnito empowers healthcare providers by driving and amplifying Electronic Medical Records systems (EMR), one of the cornerstones for digital adoption in the sector. Less than a year into the launch, Augnito is used by 5000+ doctors in 24 states.